The short answer
Tamoxifen lowers the risk of breast cancer coming back or developing, but slightly raises the risk of endometrial cancer. For most who need it, the breast cancer benefit far outweighs this small risk.
Tamoxifen is classified as a known human carcinogen (IARC Group 1).
People are mainly exposed by taking it as prescribed for breast cancer treatment or prevention.
It is most strongly linked to a small increase in endometrial cancer risk.
A carcinogen classification describes hazard — whether something can cause cancer — not your personal risk at a given exposure.
Choose how you want to understand this
The full explanation.
The simple version
Tamoxifen is a medicine that blocks estrogen in breast tissue, which helps treat and prevent certain breast cancers. In the uterus, though, it acts differently and slightly raises the risk of endometrial cancer. For most people who need it, the breast cancer benefit is much larger than this small risk.
What tamoxifen is
Tamoxifen is a selective estrogen receptor modulator (SERM). It reduces the risk of hormone-receptor-positive breast cancer returning or developing, but because it can stimulate the uterine lining, it is classified as carcinogenic to humans for endometrial cancer.
How people are exposed
Common ways people come into contact with it:
- Taking tamoxifen to treat or lower the risk of breast cancer
- Typically taken for several years as prescribed
- Guided and monitored by an oncology team
The cancer connection
Tamoxifen slightly increases the risk of endometrial (uterine) cancer, while substantially lowering breast cancer risk in people who need it.
The International Agency for Research on Cancer (IARC), the cancer arm of the World Health Organization, places tamoxifen in Group 1, carcinogenic to humans — the strongest evidence category, meaning there is enough evidence that it can cause cancer in people. In the United States, the National Toxicology Program's Report on Carcinogens lists it as known to be a human carcinogen.
Hazard is not the same as risk
It helps to separate two ideas that are easy to mix up: hazard and risk. When an agency lists tamoxifen as a carcinogen, it is making a statement about hazard — whether the substance is capable of causing cancer under some conditions. It is not, by itself, a statement about your personal risk, which depends on how much you are exposed to, for how long, and other factors. Two substances in the same group can carry very different real-world risks. The label answers "can it cause cancer?" — not "how likely is it to cause cancer for me?"
How to lower your exposure
- Report any unusual vaginal bleeding to your doctor promptly
- Keep up with recommended gynecologic follow-up
- Weigh the large breast cancer benefit against the small uterine risk with your team
If you are looking at your overall cancer risk, small, steady steps add up. See our overview of cancer prevention and what raises cancer risk to put any single exposure in context.
The bottom line
Tamoxifen is a known human carcinogen (IARC Group 1). The most important thing you can do is understand where exposure comes from and take reasonable steps to reduce it, without losing sleep over a single label. Focus your energy on the biggest, most controllable risks in your own life.
Words to know
Tap any term to see what it means.
Common questions
▸Does tamoxifen cause cancer?
Yes. Tamoxifen is classified as a known human carcinogen, which means there is strong evidence it can cause cancer in people. How much any one person's risk rises depends on how much they are exposed to and for how long.
▸How are people exposed to tamoxifen?
Most exposure happens by taking it as prescribed for breast cancer treatment or prevention. This is a prescribed medicine; the benefit-risk balance is individual and usually strongly favors treatment.
▸Which cancers are linked to tamoxifen?
It is most strongly linked to a small increase in endometrial cancer risk.
▸How can I reduce my exposure to tamoxifen?
The main steps are reporting unusual bleeding and keeping up with follow-up.
▸Does a carcinogen label mean I will get cancer?
No. A classification is about hazard — whether tamoxifen can cause cancer under some conditions — not a prediction that any one exposed person will develop cancer. Your actual risk depends on the amount and length of exposure and other factors.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Test your knowledge
0 of 4 answered
This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.